RSCM
CLLS

Rock Springs Capital Management’s Cellectis CLLS Stock Holding History

Rock Springs Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-75,000
Closed -$2.59M – 119
2015
Q1 		$2.59M Buy
+75,000
New +$2.72M 0.24% 92

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Rock Springs Capital Management's CLLS Position: Q2 2015 in Review

Rock Springs Capital Management sold out of Cellectis (CLLS) in Q2 2015, closing a stake of 75,000 shares — an estimated $2.59M sold.

Rock Springs Capital Management first reported a position in CLLS in Q1 2015 and held it in 1 quarter. The position peaked at $2.59M in Q1 2015. 40 funds tracked by Wall St. Rank hold CLLS as of Q2 2015.

  • Rock Springs Capital Management reported no remaining Cellectis position as of Q2 2015 after selling out during the quarter.
  • Rock Springs Capital Management sold 75,000 Cellectis shares in Q2 2015, an estimated $2.59M.
  • Rock Springs Capital Management first reported a position in Cellectis in Q1 2015 and held it in 1 quarter.
  • Rock Springs Capital Management's Cellectis position peaked at $2.59M in Q1 2015.
  • 40 funds tracked by Wall St. Rank held Cellectis as of Q2 2015.

Based on Rock Springs Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.